Intelligent Antibiotics for an evolving threat
The rise of multidrug resistant superbacteria has rendered many antimicrobials useless while millions die. We discover synergies between approved drugs and create more effective therapies.
Methicillin-resistant Staphylococcus aureus (MRSA) kills thousands of patients every year.
1 in 8 septic MRSA patients loses their life to this evolving threat.
We are developing a therapy that could save these lives.